Literature DB >> 21603964

Patterns of missing mini mental status exam (MMSE) in radiation therapy oncology group (RTOG) brain cancer trials.

K Bae1, D W Bruner, S Baek, B Movsas, B W Corn, J J Dignam.   

Abstract

The Mini Mental Status Exam (MMSE) instrument has been commonly used in the Radiation Therapy Oncology Group (RTOG) to assess mental status in brain cancer patients. Evaluating patient factors in relation to patterns of incomplete MMSE assessments can provide insight into predictors of missingness and optimal MMSE collection schedules in brain cancer clinical trials. This study examined eight RTOG brain cancer trials with ten treatment arms and 1,957 eligible patients. Patient data compliance patterns were categorized as: (1) evaluated at all time points (Complete), (2) not evaluated from a given time point or any subsequent time points but evaluated at all the previous time points (Monotone drop-out), (3) not evaluated at any time point (All missing), and (4) all other patterns (Mixed). Patient characteristics and reasons for missingness were summarized and compared among the missing pattern groups. Baseline MMSE scores and change scores after radiation therapy (RT) were compared between these groups, adjusting for differences in other characteristics. There were significant differences in frequency of missing patterns by age, treatment type, education, and Zubrod performance status (ZPS; P < 0.001). Ninety-two percent of patients were evaluated at least once: seven percent of patients were complete pattern, 49% were Monotone pattern, and 36% were mixed pattern. Patients who received RT only regimens were evaluated at a higher rate than patients who received RT + other treatments (49-64% vs. 27-45%). Institutional error and request to not be contacted were the most frequent known reasons for missing data, but most often, reasons for missing MMSE was unspecified. Differences in baseline mean MMSE scores by missing pattern (Complete, Monotone dropout, Mixed) were statistically significant (P < 0.001) but differences were small (<1.5 points) and significance did not persist after adjustment for age, ZPS, and other factors related to missingness. Post-RT change scores did not differ significantly by missing pattern. While baseline and change scores did not differ widely by missing pattern for available measurements, incomplete data was common and of unknown reason, and has potential to substantially bias conclusions. Higher compliance rates may be achievable by addressing institutional compliance with assessment schedules and patient refusal issues, and further exploration of how educational and health status barriers influence compliance with MMSE and other tools used in modern neurocognitive batteries.

Entities:  

Mesh:

Year:  2011        PMID: 21603964     DOI: 10.1007/s11060-011-0603-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  11 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Generalized linear mixture models for handling nonignorable dropouts in longitudinal studies.

Authors:  G M Fitzmaurice; N M Laird
Journal:  Biostatistics       Date:  2000-06       Impact factor: 5.899

Review 3.  Statistical analysis of quality of life with missing data in cancer clinical trials.

Authors:  A B Troxel; D L Fairclough; D Curran; E A Hahn
Journal:  Stat Med       Date:  1998 Mar 15-Apr 15       Impact factor: 2.373

Review 4.  Guidelines for reporting results of quality of life assessments in clinical trials.

Authors:  M Staquet; R Berzon; D Osoba; D Machin
Journal:  Qual Life Res       Date:  1996-10       Impact factor: 4.147

5.  Annotation: what can be done about missing data? Approaches to imputation.

Authors:  D F Heitjan
Journal:  Am J Public Health       Date:  1997-04       Impact factor: 9.308

6.  Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression.

Authors:  Christina A Meyers; Kenneth R Hess
Journal:  Neuro Oncol       Date:  2003-04       Impact factor: 12.300

Review 7.  Missing quality of life data in cancer clinical trials: serious problems and challenges.

Authors:  J Bernhard; D F Cella; A S Coates; L Fallowfield; P A Ganz; C M Moinpour; P Mosconi; D Osoba; J Simes; C Hürny
Journal:  Stat Med       Date:  1998 Mar 15-Apr 15       Impact factor: 2.373

8.  Pattern mixture models for longitudinal quality of life studies in advanced stage disease.

Authors:  Donna K Pauler; Sheryl McCoy; Carol Moinpour
Journal:  Stat Med       Date:  2003-03-15       Impact factor: 2.373

9.  Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination.

Authors:  Paul D Brown; Jan C Buckner; Judith R O'Fallon; Nancy L Iturria; Cerise A Brown; Brian P O'Neill; Bernd W Scheithauer; Robert P Dinapoli; Robert M Arusell; Walter J Curran; Ross Abrams; Edward G Shaw
Journal:  J Clin Oncol       Date:  2003-07-01       Impact factor: 44.544

10.  Assessing quality of life in a randomized clinical trial: correcting for missing data.

Authors:  Nina Gunnes; Taral G Seierstad; Steinar Aamdal; Paal F Brunsvig; Anne-Birgitte Jacobsen; Stein Sundstrøm; Odd O Aalen
Journal:  BMC Med Res Methodol       Date:  2009-04-30       Impact factor: 4.615

View more
  4 in total

1.  Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.

Authors:  Paul D Brown; Stephanie Pugh; Nadia N Laack; Jeffrey S Wefel; Deepak Khuntia; Christina Meyers; Ali Choucair; Sherry Fox; John H Suh; David Roberge; Vivek Kavadi; Soren M Bentzen; Minesh P Mehta; Deborah Watkins-Bruner
Journal:  Neuro Oncol       Date:  2013-08-16       Impact factor: 12.300

2.  Do reminder emails and past due notifications improve patient completion and institutional data submission for patient-reported outcome measures?

Authors:  Stephanie L Pugh; Joseph P Rodgers; Jennifer Moughan; Roseann Bonanni; Jaskaran Boparai; Ronald C Chen; James J Dignam; Deborah W Bruner
Journal:  Qual Life Res       Date:  2020-09-07       Impact factor: 4.147

Review 3.  Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology Clinic.

Authors:  Jennifer K Matsui; Haley K Perlow; Cyril Baiyee; Alex R Ritter; Mark V Mishra; Joseph A Bovi; Vinai Gondi; Paul D Brown; Ashlee R Loughan; Heather E Leeper; Erica Dawson; Joshua D Palmer
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

4.  The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy.

Authors:  Nadia N Laack; Stephanie L Pugh; Paul D Brown; Sherry Fox; Jeffrey S Wefel; Christina Meyers; Ali Choucair; Deepak Khuntia; John H Suh; David Roberge; Merideth M Wendland; Deborah Bruner
Journal:  Neurooncol Pract       Date:  2018-12-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.